The board that fired Arcturus Therapeutics co-founder and CEO Joseph E. Payne earlier this year unleashed a new broadside this week in the ongoing battle for control of the San Diego-based RNA drug developer.
In a lawsuit filed Tuesday (see below) and in an open letter to shareholders issued Wednesday, the Arcturus (NASDAQ: ARCT) board says a pattern of alleged misconduct, deceit, and failed leadership by Payne led to his termination on January 25. The allegations include attempting to give Arcturus assets to a friend’s biotech company for free, and operating a side business on company time.
Payne, who… Read more »
UNDERWRITERS AND PARTNERS